We are live on ! Find out more
Westfield Capital Management

Westfield Capital Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$16.4B
AUM Growth
-$424M
Cap. Flow
-$337M
Cap. Flow %
-2.05%
Top 10 Hldgs %
18.17%
Holding
344
New
32
Increased
105
Reduced
137
Closed
45

Sector Composition

Rank Sector Weight
1 Healthcare 19.71%
2 Technology 14.97%
3 Industrials 13.61%
4 Consumer Discretionary 10.6%
5 Communication Services 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPHI
276
DELISTED
INPHI CORPORATION
IPHI
$512K ﹤0.01%
35,600
ILG
277
DELISTED
ILG, Inc Common Stock
ILG
$512K ﹤0.01%
26,900
NEU icon
278
NewMarket
NEU
$8.21B
$492K ﹤0.01%
1,290
KO icon
279
Coca-Cola
KO
$374B
$436K ﹤0.01%
10,210
CB
280
DELISTED
CHUBB CORPORATION
CB
$435K ﹤0.01%
4,779
APD icon
281
Air Products & Chemicals
APD
$66.8B
$432K ﹤0.01%
3,589
-15,637
-81% -$1.91M
CSII
282
DELISTED
Cardiovascular Systems, Inc.
CSII
$432K ﹤0.01%
18,300
PLL
283
DELISTED
PALL CORP
PLL
$402K ﹤0.01%
4,800
-4,800
-50% -$393K
CEMP
284
DELISTED
Cempra, Inc.
CEMP
$401K ﹤0.01%
36,560
MWA icon
285
Mueller Water Products
MWA
$4.24B
$399K ﹤0.01%
48,200
MDCO
286
DELISTED
Medicines Co
MDCO
$377K ﹤0.01%
16,900
-5,300
-24% -$135K
SGMO
287
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$367K ﹤0.01%
34,000
OCRX
288
DELISTED
Ocera Therapeutics, Inc.
OCRX
$320K ﹤0.01%
+65,282
New +$377K
FSLR icon
289
First Solar
FSLR
$26.2B
$299K ﹤0.01%
4,540
+600
+15% +$40.6K
VTR icon
290
Ventas
VTR
$47.3B
$292K ﹤0.01%
4,132
SUNE
291
DELISTED
SUNEDISON, INC COM
SUNE
$278K ﹤0.01%
+14,730
New +$316K
MMM icon
292
3M
MMM
$93.2B
$268K ﹤0.01%
2,265
BXP icon
293
Boston Properties
BXP
$11B
$255K ﹤0.01%
2,200
EMR icon
294
Emerson Electric
EMR
$87.5B
$250K ﹤0.01%
4,000
CVX icon
295
Chevron
CVX
$371B
$239K ﹤0.01%
2,000
BIIB icon
296
Biogen
BIIB
$30.5B
$228K ﹤0.01%
690
BA icon
297
Boeing
BA
$184B
$217K ﹤0.01%
1,700
SRE icon
298
Sempra
SRE
$55.1B
$211K ﹤0.01%
4,000
LMT icon
299
Lockheed Martin
LMT
$135B
$210K ﹤0.01%
+1,150
New +$196K
ACAD icon
300
Acadia Pharmaceuticals
ACAD
$4.9B
-2,308,261
Closed -$52.1M

Similar funds

Westfield Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Westfield Capital Management held 344 positions worth $16.4B, down 2.5% from $16.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Westfield Capital Management's Q3 2014 filing shows 32 new, 105 increased, 137 reduced and 45 closed positions. Its largest new stake was Endo International plc: 2,599,669 shares worth $178M. The largest sale was Viacom Inc. Class B, an estimated $180M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Westfield Capital Management's largest Q3 2014 buy was Endo International plc: 2,599,669 shares worth $178M.
  • Westfield Capital Management added most to Microsoft in Q3 2014, an estimated $219M increase.
  • Westfield Capital Management's biggest Q3 2014 reduction was American International, cutting an estimated $151M.
  • Westfield Capital Management fully exited Viacom Inc. Class B in Q3 2014, selling an estimated $180M.
  • Westfield Capital Management's ten largest holdings make up 18% of its $16.4B portfolio in Q3 2014.
  • Westfield Capital Management opened 32 new positions and closed 45 in Q3 2014.
  • Westfield Capital Management's portfolio value fell 2.5% quarter-over-quarter to $16.4B.

Based on Westfield Capital Management's 13F filing for Q3 2014, filed 12 Nov 2014.